Targeting the Wnt signaling network in endometriosis: mechanistic insights and translational opportunities†

Ye X, Xiaoye Ye, Fei Lv, Lv F, Aolin Zheng, Zheng A, Shuchen Yu, Yu S, Xia S, Shiyu Xia, Yi Jin, Jin Y, Xinyi Yang, Yang X, Qihang Zhao, Zhao Q, Huanqing Chen, Chen H, Chen B, Binyan Chen, Hu Y, Ying Hu, Yongfeng Wu, Wu Y, Jinyi Tong
Biology of reproduction · 2026 · vol. 115(1) , pp. 10–18 · doi:10.1093/biolre/ioag071 · PMID:42102134 · W7160640450
review OA: closed public-domain-us
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This review details how Wnt/β-catenin signaling drives endometriosis progression through altered proliferation, invasion, and fibrosis, and explores potential targeted therapies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a chronic gynecological disorder defined by the growth of endometrial-like tissue outside the uterus, driven by estrogen-dependent inflammation and progressive fibrosis. According to available data, remodeling and persistent abnormal activation of the Wnt/β-catenin signaling network constitute one of the main molecular bases underlying its progression. Pathological characteristics of this disease include increased proliferation and anti-apoptotic potential of ectopic endometrial cells, as well as invasive phenotypes and progressive fibrosis. The Wnt/β-catenin pathway contributes to these changes through multiple levels of regulation. The pathway modifies the ligand-receptor spectrum within ectopic lesions at the level of ligand-receptor interactions. Certain canonical or non-canonical branches are more likely to be activated due to imbalanced expression of Wnt ligands and Frizzled receptors. This biased activation promotes β-catenin accumulation and nuclear translocation. In parallel, the pathway is modulated by Wnt antagonists and microRNAs. Additionally, it interacts with estrogen-progesterone imbalance, inflammatory mediators, and the immune microenvironment. The pathological processes of endometriosis are co-shaped by these signals. This review provides an organized overview of the roles of Wnt signaling in endometriosis. First, the upstream regulators of Wnt signaling and its interactions with the microenvironment are summarized. Second, the pathological effects of prolonged activation are explained, emphasizing epithelial-mesenchymal transition, fibrosis, and immune evasion. Third, the therapeutic potential of targeting this pathway is assessed, including small-molecule inhibitors, drug repurposing approaches, and nucleic acid- or epigenetic-based techniques. Finally, we propose a conceptual framework for precision treatment and targeted intervention in endometriosis, aiming to offer clinically relevant reference points.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Wnt Signaling Pathway Wnt Signaling Pathway

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (71)

SciLite annotations

chemicals 2
estrogen progesterone

Source provenance

europepmc
last seen: 2026-07-30T06:25:42.655704+00:00
openalex
last seen: 2026-07-30T06:08:59.260406+00:00
pubmed
last seen: 2026-07-30T06:12:12.430013+00:00
scilite
last seen: 2026-06-21T06:47:03.627287+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine